fda compounding semaglutide enforcement november 2025 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA and Novo Nordisk Warned

It highlights the importance of metabolism in weight management and opens doors for future therapies that target multiple pathways.

For instance, a cup of brewed coffee has 96 milligrams of caffeine

Un ejemplo claro es el descenso de los niveles de hemoglobina glucosilada (HbA1c), que marca una mejora en el control glucmico

The severity and frequency of these side effects may vary from person to person

Exendin-4 was reported to reduce relapse-like drinking behavior in mice, delaying the onset of renewed alcohol consumption and decreasing the number of drinking bouts

As interest in Retatrutide Pens in the UK continues to grow, many people are looking for reliable guidance on administration, dosing and safe use